NDC Package Code : 51552-0293
Start Marketing Date : 1998-04-01
End Marketing Date : 2025-12-11
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
NDC Package Code : 51552-0293
Start Marketing Date : 1998-04-01
End Marketing Date : 2025-12-11
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
FINISHED DOSAGE FORMULATIONS
Drug : LIDOCAINE
Dosage Form : OINTMENT; TOPICAL
Application Number : 210958
Country : US
Patented : No
Drug : ANASTROZOLE
Dosage Form : TABLET; ORAL
Application Number : 90568
Country : US
Patented : No
Drug : LIDOCAINE
Dosage Form : OINTMENT; TOPICAL
Application Number : 211469
Country : US
Patented : No
Drug : LIDOCAINE
Dosage Form : OINTMENT; TOPICAL
Application Number : 207810
Country : US
Patented : No
Drug : METHOCARBAMOL
Dosage Form : SOLUTION; IM-IV
Application Number : 207496
Country : US
Patented : No
Drug : LIDOCAINE
Dosage Form : OINTMENT; TOPICAL
Application Number : 206297
Country : US
Patented : No
Drug : ARIMIDEX
Dosage Form : TABLET; ORAL
Application Number : 20541
Country : US
Patented : No
Drug : CASODEX
Dosage Form : TABLET; ORAL
Application Number : 20498
Country : US
Patented : No
Drug : LIDOCAINE
Dosage Form : OINTMENT; TOPICAL
Application Number : 211019
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS
MARKET PLACE